Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers

Dr Tanios Bekaii-Saab from the Mayo Clinic Cancer Center in Phoenix, Arizona, and Dr John Strickler from Duke University in Durham, North Carolina, review clinical data supporting the application of HER2-targeted therapies for patients with gastrointestinal cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.

Episode metadata supplied by the publisher feed · Published Sep 11, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers

0:00 1:00:59

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Today with Dr Neil Love?

This episode is 1 hour and 0 minutes long.

When was this Oncology Today with Dr Neil Love episode published?

This episode was published on September 11, 2024.

Can I download this Oncology Today with Dr Neil Love episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!